Skip to main content
. 2020 Jun 5;64(3):290–297. doi: 10.20945/2359-3997000000251

Table 1. Patients baseline characteristics.

  Total Sample (N = 357) Study group Control vs. Metformin P Value

Control (N = 186) Metformin (N = 171)
Age (SD) 29.1 (6.2) 29.6 (6.1) 28.6 (6.2) 0.12*
Ethnicity        
White 279 (78.2) 140 (75.3) 139 (81.3) 0.38**
Black 47 (13.2) 28 (15.1) 19 (11.1)
Other 31 (8.7) 18 (9.7) 13 (7.6)
Marital status        
Single 58 (16.2) 26 (14.0) 32 (18.7) < 0.01**
Married 259 (72.5) 147 (79.0) 112 (65.5)
Other 40 (11.2) 13 (7.0) 27 (15.8)
Education        
< 18 years 50 (14.0) 24 (12.9) 26 (15.2) 0.23**
Middle school 105 (29.4) 50 (26.9) 55 (32.2)
High school 166 (46.5) 88 (47.3) 78 (45.6)
College 36 (10.1) 24 (12.9) 12 (7.0)
Number of pregnancies (SD) 2.7 (2.0) 2.7 (2.0) 2.6 (2.0) 0.73*
Intake GA (SD) 11.4 (3.2) 11.3 (3.1) 11.5 (3.2) 0.62*
Gestational BMI (≥ 30 kg/m2) (SD)        
Intake BMI 37.4 (5.2) 37.2 (5.7) 37.5 (4.6) 0.26***
3rd Trimester BMI 38.8 (6.2) 38.9 (6.3) 38.7 (6.1) 0.33***

SD: standard deviation; GA: gestational age; BMI: body mass index. Statistical tests: *T test; **Chi-square. ***Mann-Whitney.